Long Term Effects of DPP-IV Inhibitor Treatment in Patients With Type 2 Diabetes
Status:
Completed
Trial end date:
2009-03-01
Target enrollment:
Participant gender:
Summary
We wish to evaluate the effect of long term treatment with a DPP-IV inhibitor on the function
of the incretin hormones
Hypothesis We hypothesize that that a gradual improvement in metabolic control induced by
DPP-IV inhibitor (Januvia®) treatment significantly ameliorates the impaired secretion and
potency of GLP-1 and leads to a restoration of the lost action of GIP.